AdaptHealth (NASDAQ:AHCO) Hits New 12-Month Low - Should You Sell?

AdaptHealth Corp. (NASDAQ:AHCO - Get Free Report) reached a new 52-week low during trading on Tuesday . The company traded as low as $8.11 and last traded at $8.22, with a volume of 2070082 shares changing hands. The stock had previously closed at $8.66.

Analysts Set New Price Targets

AHCO has been the subject of a number of research reports. Royal Bank of Canada boosted their price target on shares of AdaptHealth from $11.00 to $14.00 and gave the company an "outperform" rating in a research report on Wednesday, February 26th. Canaccord Genuity Group lifted their price target on AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. UBS Group decreased their price objective on AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a report on Thursday, February 13th. Robert W. Baird raised their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. Finally, Truist Financial upped their price target on shares of AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, AdaptHealth presently has an average rating of "Buy" and an average price target of $13.80.

AdaptHealth Stock Performance

The company has a market cap of $1.05 billion, a PE ratio of -4.72, a P/E/G ratio of 1.08 and a beta of 1.44. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The stock's 50-day simple moving average is $9.70 and its 200 day simple moving average is $9.96.

Institutional Investors Weigh In On AdaptHealth

Hedge funds have recently added to or reduced their stakes in the company. Pacer Advisors Inc. purchased a new position in shares of AdaptHealth during the 4th quarter worth approximately $76,271,000. Reinhart Partners LLC. grew its holdings in AdaptHealth by 15.5% during the first quarter. Reinhart Partners LLC. now owns 7,236,262 shares of the company's stock worth $78,441,000 after acquiring an additional 969,408 shares during the period. Segall Bryant & Hamill LLC raised its position in AdaptHealth by 29.8% in the fourth quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company's stock worth $45,734,000 after acquiring an additional 1,102,173 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in AdaptHealth by 17.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,379,715 shares of the company's stock valued at $32,174,000 after acquiring an additional 505,180 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in AdaptHealth by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 2,467,769 shares of the company's stock valued at $23,499,000 after acquiring an additional 16,596 shares during the period. Institutional investors and hedge funds own 82.67% of the company's stock.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.